共 44 条
- [1] Stahl SM(2011)Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder J Sex Med 8 15-27
- [2] Sommer B(2016)Maximierung der Sicherheit von Flibanserin: Die Rolle von Aufsichtsbehörden, Kliniken und Patientinnen Z Sexualforsch 29 176-186
- [3] Allers KA(2014)Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin BJOG 121 1328-1331
- [4] Baksh S(2017)Hypoactive Sexual Desire Disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) Expert Consensus Panel Review Mayo Clin Proc 92 114-128
- [5] Gellad W(2010)Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder J Med Econ 13 583-590
- [6] Caleb A(2008)Sexual problems and distress in United States women: prevalence and correlates Obstet Gynecol 112 970-978
- [7] Thorp J(2006)Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS) Menopause 13 46-56
- [8] Goldstein I(2011)Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors J Sex Med 8 2420-2430
- [9] Foley K(2008)Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women Arch Intern Med 168 1441-1449
- [10] Foley D(2007)Relationship between hypoactive sexual desire disorder and aging Fertil Steril 87 107-112